Neuland Laboratories Ltd. · NSE:NEULANDLAB
Neuland Laboratories — Earnings Presentation (2016)
6 slides from Neuland Laboratories's earnings presentation, 2016
Slide 1: Neuland Quarterly Investor Update: Addition of New Business Indicators
Neuland Quarterly Investor Update Addition of New Business Indicators © 2016, Neuland Laboratories Limited. All Rights Reserved
Slide 2: Introduction
Introduction In addition to the regular Financial information and qualitative updates, Neuland will also report two new Indicators which will give investors a deeper insight into the company’s performance and the company’s prospects The purpose of this presentation is to introduce those paramete
Slide 3: Business Saliency
Business Saliency For the past few quarters, Neuland has engaged with the Investor community and talked about business in terms of Prime Products, Niche Products and the CMS business. From here on, we will indicate the contribution of the respective Business segment to Neuland revenues under the Ind
Slide 4: Business Saliency
Business Saliency The graphs below show the Saliency of the Last 3 Financial Years and over the Last Four quarters. Hence forth, we will reporting this Indicator for 4-quarters on a rolling-basis FY14-16 FY-16 11% 4% 13% 17% 16% 22% 24% 18% 30% 22% 27% 26% 25% 25% 71% 65% 66% 57% 53% 57% 51% FY-14 F
Slide 5: CMS Business Depth
CMS Business Depth This Indicator will give the number of molecules (APIs and Intermediates) contributing to the revenue in the Quarter. This number will be classified in two parts as Clinical & Commercial based on the status of the respective molecules. The intent here is to give an idea of the dep
Slide 6: Thank You
A WHERE OPPORTUNITY BECOMES REALITY Thank You